A device specifically designed to prevent readmissions and in hospital stay of patients with congestive heart failure

• Insertion under local anesthesia: key hole approach (minimally invasive)
• On demand device to treat CHF exacerbation.
• Subsequent office based care (no need for admission to hospital)
• Robust circulatory support to help tailor medical therapy.
• Avoids adverse events (pump thrombosis, GI bleeding, strokes and infection) that plague current LVAD devices (HeartMate, HertWare, Jarvik and MicroMed Debakey pumps)
• Device battery charged/powered wirelessly with no need for any dressing changes/external leads.
• International PCT patent application ‘Heart Failure Recovery Device and Method of Treatment’

The HFR device include a pump, a coil for wireless charging and a purging system to start/stop & clean the pump without surgery.